SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 10, 2026

APGE

Apogee Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $3.4M total
Actionable Insight • Neutral

Cluster sales are too small to read as bearish, treat as routine portfolio diversification. Monitor for any acceleration in insider selling volume in coming weeks.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$133.82
T+0 close · Jul 10, 2026 · via day close
Latest settled
+0.62%
T+20 · $134.65
Vs SPY
−2.56%
α at T+20
Next horizon
T+60
due 6w ago
  1. T+0 · Jul 13 $133.82entry
  2. T+1 · 4mo ago +0.10%α −0.25% · $133.96
  3. T+5 · 4mo ago +0.13%α +0.92% · $134.00
  4. T+20 · 3mo ago +0.62%α −2.56% · $134.65
  5. T+60 · due 6w ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Michael Thomas Henderson sold $2.67M and CMO Carl Dambkowski sold $730K of APGE shares in a small cluster. Combined sales of $3.4M represent just 0.034% of the $10.1B market cap, a trivial amount with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$3.4M
Insiders
2

Key Facts

  • CEO sold 20,000 shares at $133.63 for $2.67M on 2026-07-08
  • CMO sold 5,500 shares at $132.74 for $730K on 2026-07-01
  • Total cluster value $3.4M, only 0.034% of $10.1B market cap
  • CEO also gifted 75,046 shares (non-cash transfer) on 2026-07-10

Financial Impact

Insider sales of $3.4M, negligible relative to $10.1B market cap

dilution (none)

Risk Factors

  • Potential future selling if executives continue to reduce positions
  • No immediate risk from current cluster

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
33% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-APGE-1783728044958

Track record

31 reports on APGE

Performance horizon

9 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +73.31% at T+60 after the May 27, 2026 report. 12 of 13 went positive at some point.

Filters
  1. Sep 14, 20269w ago 15-12G Neutral 4/10 No price data
  2. Sep 3, 202610w ago 25-NSE Bullish 8/10 Entry $135.06 No price data
  3. Sep 3, 202610w ago 8-K Bullish 8/10 Entry $135.06 No price data
  4. Aug 11, 202613w ago 8-K Bullish 7/10 Entry $134.55 No price data
  5. Aug 10, 202614w ago 8-K Bullish 8/10 No price data
  6. Aug 10, 202614w ago Press Release Bullish 8/10 Entry $134.65 No price data
  7. Aug 6, 202614w ago Institutional Cluster Mixed 5/10 Entry $134.49 to $135.07 ▲ +0.43% −0.17% vs SPY
  8. Aug 3, 202615w ago DEFA14A Bullish 5/10 Entry $134.19 to $135.08 ▲ +0.66% +1.90% vs SPY
  9. Jul 10, 202618w ago Insider Cluster Neutral 2/10 Viewing Entry $133.82 to $134.65 ▲ +0.62% −2.56% vs SPY
  10. Jun 26, 202620w ago DEFA14A Bullish 6/10 Entry $132.61 to $134.28 ▲ +1.26% +1.54% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens in 9h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 10, 2026